SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.

Autor: Richardson SI; SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa., Mzindle N; SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa., Motlou T; SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa., Manamela NP; SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa., van der Mescht MA; Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Lambson BE; SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa., Everatt J; SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa., Amoako DG; SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; School of Health Sciences, College of Health Sciences, University of KwaZulu-Natal, KwaZulu-Natal, South Africa., Balla S; SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa., von Gottberg A; SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Wolter N; SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., de Beer Z; Tshwane District Hospital, Pretoria, South Africa., de Villiers TR; Tshwane District Hospital, Pretoria, South Africa., Bodenstein A; Tshwane District Hospital, Pretoria, South Africa., van den Berg G; Tshwane District Hospital, Pretoria, South Africa., Abdullah F; Division for Infectious Diseases, Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria, Pretoria, South Africa., Rossouw TM; Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.; Division for Infectious Diseases, Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria, Pretoria, South Africa., Boswell MT; Division for Infectious Diseases, Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria, Pretoria, South Africa., Ueckermann V; Division for Infectious Diseases, Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria, Pretoria, South Africa., Bhiman JN; SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa., Moore PL; SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.

Publikováno v: Journal of virology [J Virol] 2024 Jul 23; Vol. 98 (7), pp. e0067824. Date of Electronic Publication: 2024 Jul 02.

Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant.

Autor: Richardson SI; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa; South African Medical Research Council Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa., Kgagudi P; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa; South African Medical Research Council Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa., Manamela NP; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa; South African Medical Research Council Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa., Kaldine H; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa; South African Medical Research Council Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa., Venter EM; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa; South African Medical Research Council Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa., Pillay T; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa; South African Medical Research Council Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa., Lambson BE; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa; South African Medical Research Council Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa., van der Mescht MA; Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Hermanus T; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa; South African Medical Research Council Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa., Balla SR; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa; South African Medical Research Council Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa., de Beer Z; Tshwane District Hospital, Pretoria, South Africa., de Villiers TR; Tshwane District Hospital, Pretoria, South Africa., Bodenstein A; Tshwane District Hospital, Pretoria, South Africa., van den Berg G; Tshwane District Hospital, Pretoria, South Africa., du Pisanie M; Division for Infectious Diseases, Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria, Pretoria, South Africa., Burgers WA; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology; University of Cape Town, Cape Town, South Africa; Wellcome Centre for Infectious Disease Research in Africa, University of Cape Town, Cape Town, South Africa., Ntusi NAB; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa; Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Abdullah F; Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa; Division for Infectious Diseases, Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria, Pretoria, South Africa., Ueckermann V; Division for Infectious Diseases, Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria, Pretoria, South Africa., Rossouw TM; Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Boswell MT; Division for Infectious Diseases, Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria, Pretoria, South Africa., Moore PL; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa; South African Medical Research Council Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa. Electronic address: pennym@nicd.ac.za.

Publikováno v: Cell reports. Medicine [Cell Rep Med] 2023 Jan 17; Vol. 4 (1), pp. 100910. Date of Electronic Publication: 2022 Dec 22.

Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize Omicron.

Autor: Keeton R; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.; Division of Medical Virology, Department of Pathology, University of Cape Town; Observatory, Cape Town, South Africa., Tincho MB; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.; Division of Medical Virology, Department of Pathology, University of Cape Town; Observatory, Cape Town, South Africa., Ngomti A; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.; Division of Medical Virology, Department of Pathology, University of Cape Town; Observatory, Cape Town, South Africa., Baguma R; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.; Division of Medical Virology, Department of Pathology, University of Cape Town; Observatory, Cape Town, South Africa., Benede N; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.; Division of Medical Virology, Department of Pathology, University of Cape Town; Observatory, Cape Town, South Africa., Suzuki A; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.; Division of Medical Virology, Department of Pathology, University of Cape Town; Observatory, Cape Town, South Africa., Khan K; Africa Health Research Institute, Durban, South Africa.; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa., Cele S; Africa Health Research Institute, Durban, South Africa.; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa., Bernstein M; Africa Health Research Institute, Durban, South Africa.; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa., Karim F; Africa Health Research Institute, Durban, South Africa.; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa., Madzorera SV; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Moyo-Gwete T; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Mennen M; Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, Cape Town, South Africa., Skelem S; Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, Cape Town, South Africa., Adriaanse M; Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, Cape Town, South Africa., Mutithu D; Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, Cape Town, South Africa., Aremu O; Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, Cape Town, South Africa., Stek C; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.; Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, Cape Town, South Africa., du Bruyn E; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.; Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, Cape Town, South Africa., Van Der Mescht MA; Department of Immunology, University of Pretoria, Pretoria, South Africa., de Beer Z; Tshwane District Hospital, Tshwane, South Africa., de Villiers TR; Tshwane District Hospital, Tshwane, South Africa., Bodenstein A; Tshwane District Hospital, Tshwane, South Africa., van den Berg G; Tshwane District Hospital, Tshwane, South Africa., Mendes A; Centre for Viral Zoonoses, Department of Medical Virology, University of Pretoria, Pretoria, South Africa., Strydom A; Centre for Viral Zoonoses, Department of Medical Virology, University of Pretoria, Pretoria, South Africa., Venter M; Centre for Viral Zoonoses, Department of Medical Virology, University of Pretoria, Pretoria, South Africa., Giandhari J; KwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa., Naidoo Y; KwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa., Pillay S; KwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa., Tegally H; KwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa., Grifoni A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA., Weiskopf D; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA., Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA, USA., Wilkinson RJ; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.; Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Observatory, Cape Town, South Africa.; Department of Infectious Diseases, Imperial College London, London, UK.; The Francis Crick Institute, London, UK., de Oliveira T; KwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa.; Centre for Epidemic Response and Innovation, Stellenbosch University, Stellenbosch, South Africa., Bekker LG; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.; Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, Cape Town, South Africa.; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Gray G; South African Medical Research Council, Cape Town, South Africa., Ueckermann V; Department of Internal Medicine, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa., Rossouw T; Department of Immunology, University of Pretoria, Pretoria, South Africa., Boswell MT; Department of Internal Medicine, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa., Bhiman JN; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Moore PL; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa., Sigal A; Africa Health Research Institute, Durban, South Africa.; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.; Max Planck Institute for Infection Biology, Berlin, Germany., Ntusi NAB; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.; Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Observatory, Cape Town, South Africa.; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town; Observatory, Cape Town, South Africa., Burgers WA; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa. wendy.burgers@uct.ac.za.; Division of Medical Virology, Department of Pathology, University of Cape Town; Observatory, Cape Town, South Africa. wendy.burgers@uct.ac.za.; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Observatory, Cape Town, South Africa. wendy.burgers@uct.ac.za., Riou C; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa. cr.riou@uct.ac.za.; Division of Medical Virology, Department of Pathology, University of Cape Town; Observatory, Cape Town, South Africa. cr.riou@uct.ac.za.; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Observatory, Cape Town, South Africa. cr.riou@uct.ac.za.

Publikováno v: Nature [Nature] 2022 Apr; Vol. 604 (7907), pp. E25.